Professor Suzanne Garland , AO, MBBS, MD, FRCPA, FRANZCOG Ad Eundem, FAChSHM, FASM, FACOG Hons
Professor Garland obtained her Bachelor of Medicine at the University of Melbourne in 1971, and subsequently worked as a Research Fellow at Harvard University, Brigham and Women’s Hospital Boston, USA. Suzanne commenced as Director of Clinical Microbiology at the Women’s in 1984.
Professor Garland is a regular advisor to the World Health Organisation (WHO) on sexual and reproductive health infections, cervical cancer and human papillomavirus (HPV). Her laboratory is a Western Pacific reference laboratory for HPV for the HPV Labnet, as set up by WHO.
Professor Garland has been a chief investigator for phase 3, clinical HPV vaccine trials for the bivalent and quadrivalent vaccines, and on the Advisory Board for the nonavalent vaccine: she with her team is currently measuring vaccine effectiveness post vaccine rollout in Australia. She has 700 peer reviewed articles in the scientific literature.
Professor Garland was integral to the setup of the New Society Asia Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN) and is the Inaugural and Past President of AOGIN and ongoing Board Advisor.
She is currently the Director of Centre Women’s Infectious Diseases Research, Royal Women’s Hosptial, holds an Honorary Research Fellow position at Murdoch Children’s Research Institute, and Professorial Chair through the Department of Obstetrics and Gynaecology at the University of Melbourne, President Elect IPVS and recent recipient of Officer of the Order of Australia, AO.